Susceptibilities of 540 anaerobic gram-negative bacilli to amoxicillin, amoxicillin-BRL 42715, amoxicillin-clavulanate, temafloxacin, and clindamycin.
作者信息
Appelbaum P C, Spangler S K, Shiman R, Jacobs M R
机构信息
Department of Pathology (Clinical Microbiology), Hershey Medical Center, Pennsylvania 17033.
出版信息
Antimicrob Agents Chemother. 1992 May;36(5):1140-3. doi: 10.1128/AAC.36.5.1140.
Abstract
Agar dilution MIC testing of amoxicillin, amoxicillin-BRL 42715, amoxicillin-clavulanate, temafloxacin, and clindamycin against 496 beta-lactamase-producing anaerobic gram-negative rods revealed MICs for 90% of the strains tested of 256.0 (amoxicillin), 2.0 (amoxicillin-BRL 42715 and amoxicillin-clavulanate), and 4.0 (temafloxacin and clindamycin) microgram/ml. Amoxicillin, temafloxacin, and clindamycin inhibited all 44 beta-lactamase-negative strains (MICs for 90% of the strains tested, less than or equal to 2.0 micrograms/ml). BRL 42715 will not be developed, but temafloxacin merits clinical evaluation.
摘要
相似文献
1
Susceptibilities of 540 anaerobic gram-negative bacilli to amoxicillin, amoxicillin-BRL 42715, amoxicillin-clavulanate, temafloxacin, and clindamycin.
Antimicrob Agents Chemother. 1992 May;36(5):1140-3. doi: 10.1128/AAC.36.5.1140.
2
Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.
Antimicrob Agents Chemother. 1993 Aug;37(8):1649-54. doi: 10.1128/AAC.37.8.1649.
3
[Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the pediatric field].
Jpn J Antibiot. 1985 Feb;38(2):342-58.
4
[In vitro susceptibilities of BRL 25000 (clavulanic acid-amoxicillin) against causative organisms in the field of obstetrics and gynecology].
Jpn J Antibiot. 1986 Mar;39(3):842-52.
5
Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology.
Antimicrob Agents Chemother. 1999 Aug;43(8):2027-31. doi: 10.1128/AAC.43.8.2027.
6
beta-Lactamase production and susceptibility of US and European anaerobic gram-negative bacilli to beta-lactams and other agents.
Eur J Clin Microbiol Infect Dis. 1992 Nov;11(11):1081-93. doi: 10.1007/BF01967803.
7
Sensitivity of clinical isolates from German hospitals to amoxicillin/clavulanic acid (Augmentin) compared with other antibiotics.
Chemotherapy. 1988;34(4):332-40. doi: 10.1159/000238588.
8
[Laboratory and clinical studies of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Jpn J Antibiot. 1985 Feb;38(2):431-40.
9
Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.
Antimicrob Agents Chemother. 1990 Aug;34(8):1546-50. doi: 10.1128/AAC.34.8.1546.
10
In vitro activity of amoxycillin/clavulanate and ticarcillin/clavulanate compared with that of other antibiotics against anaerobic bacteria: comparison with the results of the 1987 survey.
Acta Clin Belg. 1996;51(2):70-9. doi: 10.1080/17843286.1996.11718489.
引用本文的文献
1
In vitro activities of cefminox against anaerobic bacteria compared with those of nine other compounds.
Antimicrob Agents Chemother. 1998 Mar;42(3):495-501. doi: 10.1128/AAC.42.3.495.
2
Quinolone activity against anaerobes: microbiological aspects.
Drugs. 1995;49 Suppl 2:76-80. doi: 10.2165/00003495-199500492-00012.
3
Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.
Antimicrob Agents Chemother. 1993 Aug;37(8):1649-54. doi: 10.1128/AAC.37.8.1649.
4
Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clindamycin, and metronidazole against 384 anaerobic bacteria.
Antimicrob Agents Chemother. 1994 Nov;38(11):2599-604. doi: 10.1128/AAC.38.11.2599.
5
beta-Lactamase production and susceptibility of US and European anaerobic gram-negative bacilli to beta-lactams and other agents.
Eur J Clin Microbiol Infect Dis. 1992 Nov;11(11):1081-93. doi: 10.1007/BF01967803.
本文引用的文献
1
Survey of anaerobic susceptibility patterns in Canada.
Antimicrob Agents Chemother. 1986 Nov;30(5):798-801. doi: 10.1128/AAC.30.5.798.
2
Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones.
Antimicrob Agents Chemother. 1987 Nov;31(11):1768-74. doi: 10.1128/AAC.31.11.1768.
3
Comparative activity of beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes.
Antimicrob Agents Chemother. 1986 Nov;30(5):789-91. doi: 10.1128/AAC.30.5.789.
4
In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor.
Antimicrob Agents Chemother. 1989 Sep;33(9):1580-7. doi: 10.1128/AAC.33.9.1580.
5
The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacin.
J Antimicrob Chemother. 1989 Sep;24(3):415-24. doi: 10.1093/jac/24.3.415.
6
Susceptibility of Bacteroides non-fragilis and fusobacteria to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazole.
Eur J Clin Microbiol Infect Dis. 1990 Jun;9(6):417-21. doi: 10.1007/BF01979473.
7
Evaluation of two methods for rapid testing for beta-lactamase production in Bacteroides and Fusobacterium.
Eur J Clin Microbiol Infect Dis. 1990 Jan;9(1):47-50. doi: 10.1007/BF01969535.
8
Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
J Antimicrob Chemother. 1990 Sep;26(3):361-70. doi: 10.1093/jac/26.3.361.
9
Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.
Antimicrob Agents Chemother. 1990 Aug;34(8):1546-50. doi: 10.1128/AAC.34.8.1546.
10
In vitro susceptibilities of oral pigmented Bacteroides species to trospectomycin and other selected antimicrobial agents.
Antimicrob Agents Chemother. 1990 Aug;34(8):1597-9. doi: 10.1128/AAC.34.8.1597.
Zotero 插件